Menu

Important Document

Important Document

Sr. No. Title Details
101 Extension of timeline for submission of application till 08.04.2023 under PLI Scheme for Medical Devices.
102 Annual Report 2022-23 -reg.
103 Amendment in the Operational Guidelines for the Production Linked Incentive (PU) Scheme for Pharmaceuticals regarding the Scheme Selection and Steering Committee (SSSC) to regularly monitor the progress of implementation - reg.
104 Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices
105 Required Modifications in the Guidelines of Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) to invite applications for the eligible product as per Annexure-1A for Category-B applicant- reg.
106 Invitation of Applications from eligible Category-B Applicants under the Revised guidelines / corrigendum dt. 25 02.2023 of Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices
107 Payment of Honorarium to Members of National Institutes of Pharmaceutical Education & Research (NIPER) Council - regarding
108 Guidelines for Hiring of Young Professionals (non-tech) on contract basis in the Department of Pharmaceuticals-reg.
109 Guidelines for Hiring of Non-Technical Consultants on contract basis in the Department of Pharmaceuticals-reg.
110 Guidelines for Hiring of Technical Consultants/Young Professionals (Tech.) on contract basis in the Department of Pharmaceuticals-regarding.
111 Modification of certain clauses of the PTUAS Sub-scheme of the Scheme 'Strengthening of Pharmaceuticals Industry'-regarding
112 Update on PLI for Bulk Drug as on 30.12.2022
113 Seeking Comments/views/suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg
114 Extension of Timeline for Invitation of Applications from eligible Category B Applicants under the revised guidelines of PLI Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 - till 21.11.2022- reg.
115 Amendment in the Operational Guidelines for the Production Linked Incentive (PLI) Scheme for Pharmaceuticals - reg
116 Extension of one week beyond 30.9.2022 for submission of application under the sub-scheme 'Assistance to Pharmaceutical Industry for Common Facilities (APICF)' - reg
117 Constitution of High Level Committee to consider various issues pertaining to UCPMP and examine the requirement for a legally enforceable mechanism for regulating marketing practices by Pharma Companies-regarding
118 Frequently Asked Questions (FAQs)- Pharmaceutical Technology Upgradation Assistance Scheme
119 Frequently Asked Questions (FAQs)- Assistance to Pharmaceutical Industry for Common Facilities (API-CF)
120 Amendment to the Order dated 21st January, 2019 with respect to constitution of Standing Committee on Affordable Medicines and Health Products (SCAMPH) - Regarding
121 14 सितम्बर, 2022 को हिन्दी दिवस के उपलक्ष्य में सचिव (औषध) का संदेश
122 Details of Applicants approved under Production Linked Incentive (PLI) Scheme for Pharmaceuticals
123 Message from Honorable Minister (C&F) on Swachhta Pakhwada During 1-15 September 2022
124 Message from Honorable MoS (C&F) on Swachhta Pakhwada During 1-15 September 2022
125 Invitation of Applications from eligible Category B Applicants under the revised guidelines of Production Link Incentive (PU) Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 from 1st September 2022 to 31st October 2022 - reg
126 Corrigendum-Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis.
127 Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices
128 Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis - regarding
129 List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Bulk Drug Dated 8th August, 2022
130 Seeking the details of domestic manufacturers of the inputs required for manufacture of Vaccines and Biopharmaceuticals.
131 Corrigendum of PLI Scheme for Bulk Drug- Dated 26th July, 2022
132 Invitation of applications for the eligible product Vitamin B1,through chemical synthesis route under Production Linked Incentive (PLI) Scheme for Bulk Drug
133 Guidelines for the Scheme Strengthening of Pharmaceuticals Industry (SPI)- Notification of the modifications of the few clauses in the GLs - regarding
134 Filling up the post of Director (Finance) in Bengal Chemicals & Pharmaceuticals Ltd.(BCPL) through PESB selection mode.- regarding
135 O.M. dated 02.05.2022 to Central Procurement Agencies to exercise due diligence on the claims of the local manufacturers while proceeding for the procurement
136 Seeking comments/views/ suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg
137 Guidelines on Pharmaceutical Innovation & Entrepreneurship
138 FAQs on the Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme 'Strengthening of Pharmaceuticals Industry' (SPI)
139 Extension of timeline to submit proposal: Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme Strengthening of Pharmaceuticals Industry (SPI)
140 Approval accorded to the States under the scheme 'Promotion of Medical Devices Park'
141 Awards to the leading Pharma and Medical Devices Industry playersIndia Pharma 2022 & India Medical Devices 2022-Extension of Date for invitation of Applications -reg
142 Annual Report 2021-22
143 Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli
144 Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022
145 Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg.
146 Portal for India Pharma and India Medical Device Awards
147 Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022
148 Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI)
149 Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022.
150 Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022

Pages